期刊文献+

克拉屈滨治疗巨球蛋白血症后早期发生自身免疫性溶血性贫血 被引量:1

原文传递
导出
出处 《国际输血及血液学杂志》 CAS 2006年第3期277-278,共2页 International Journal of Blood Transfusion and Hematology
  • 相关文献

同被引文献13

  • 1NCCN Clinical Practice Guidelines in Oncology-Non-Hodgkin's Lymphomas,Version1.2011.
  • 2Cheson BD,Pfistner B,Juweid ME,et al.Revised response criteria for malignant lymphoma[J].J Clin Oncol,2007,25(5):579-586.
  • 3Robak T,Blonski JZ,Gora-Tybor J,et al.Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia:report of a prospective,multicenter,randomized trial of the Polish Adult Leukemia Group (PALG CLL2)[J].Blood,2006,108(2):473-479.
  • 4Robak T,Blonski JZ,Wawrzyniak E,et al.Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion:report from the Polish Adult Leukemia Group[J].Cancer,2009,115(1):94-100.
  • 5Jager G,Neumeister P,Brezinschek R,et al.Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine:a phase II study[J].J Clin Oncol,2002,20(18):3872-3877.
  • 6Tondini C,Balzarotti M,Rampinelli I,et al,Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma:a phase II randomized study[J].Ann Oncol,2000,11(2):231-233.
  • 7Nagai H,Kusumoto S.Phase II study of cladribine with rituximab (R-2-CdA) therapy in patients with relapsed indolent B-cell non-Hodgkin's lymphoma[J].J Clin Oncol,2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition),2009,27(15S):e19501.
  • 8Suzuki Y,Danbara M.Phase II:Combination of cladribine,cyclophosphamide,mitoxantrone,rituximab (R-CCM) in patients with relapsed and refractory follicular and mantle cell lymphoma,results of a prospective study at Kitasato University[J].J Clin Oncol,ASCO Annual Meeting Proceedings (Post-Meeting Edition),2007,25,18S.
  • 9Kalinka E,Wajs.Randomized Comparison of Cladribine Single (C)or in Combination with Cyclophosphamide (CC),and COP in Previously Untreated Low Grade B-Cell Non-Hodgkin Lymphoma Patients[J].Blood (ASH Annual Meeting Abstracts),2006,108.
  • 10Robak T,Jamroziak K,Gora-Tybor J,et al.Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia:a phase III randomized study by the Polish Adult Leukemia Group(PALG-CLL3 Study[J].J Clin Oncol,2010,28(11):1863-1869.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部